Insulin’s place in the treatment of people with type 2 diabetes has been transformed by the advent of new drugs, says Professor Tina Vilsbøll (Steno Diabetes Centre, Denmark). But with fixed-ratio combinations and once-weekly insulin injections in the pipeline, the journey isn’t over yet.